Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccination at 3, 5, 12 months and 5 years of age

Line M. Lindgren,Pernille N. Tingskov, Annette H. Justesen,Bettina Nedergaard,Klaus J. Olsen,Lars Vibe Andreasen,Ingrid Kromann,Charlotte Sørensen,Jes Dietrich,Birgit Thierry-Carstensen

Vaccine（2017）

Cited 6|Views34
No score
Abstract
•Three adjuvanted reduced dose IPV-Al SSI were safe and immunogenic in adolescents.•The three IPV-Al SSI were highly immunogenic, but inferior to IPV Vaccine SSI as a booster.•Reduced dose IPV-Al SSI is intended for markets in need of affordable IPV.
More
Translated text
Key words
Affordable IPV,IPV dose sparing,Dose investigation,Aluminium hydroxide adjuvant
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined